Summary
Goldman Sachs issued a research note on The a2 Milk Company on 10 November 2026, reiterating its 'buy' rating. a2 Milk is a dairy nutrition company that sells branded products made from milk naturally containing the A2 protein in specific markets. Its China and other Asia segment sells Chinese- and English-branded infant formula, natural and fortified milk powders, liquid milk and other nutritional products through physical stores and domestic and international e-commerce channels.
The note did not disclose Goldman Sachs' target price, the magnitude of any rating change or financial forecasts, nor did it specify how the rating differed from the previous one.
Commentary
Goldman Sachs' decision to maintain its buy rating on a2 Milk signals the investment bank's confidence in the resilience of the company's China and Asia business. As a New Zealand-listed dairy company, a2 Milk has carved out a position in the premium infant formula market through its A2 protein differentiation, but in recent years it has faced multiple pressures, including China's declining birth rate, the rise of local brands and tightening regulation. China's infant formula market has entered a zero-sum phase, with domestic brands such as Feihe and Yili gaining share through channel expansion into lower-tier cities and brand marketing, while a2 Milk relies on cross-border e-commerce and daigou channels and is therefore more exposed to policy shifts.
For New Zealand small and medium-sized business owners, the rating signal should be read with caution: on one hand, Goldman Sachs' endorsement may lift investor confidence, but no specific target price or earnings forecast was disclosed, leaving little substantive data; on the other hand, a2 Milk's channel structure highlights the persistent risk of dependence on a single market or channel. New Zealand small and medium-sized dairy companies and related traders should monitor compliance costs under China's infant formula registration system and changes to cross-border e-commerce tax policy, while exploring segments such as adult milk powder and functional dairy products to reduce over-reliance on infant formula.
Keywords: a2 Milk, Goldman Sachs, buy rating, infant formula, A2 protein, dairy nutrition, China and Asia markets, e-commerce channels
Photo by EclipseChasers on Pixabay
Source: MarketScreener Spain
Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.





